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specificity	 (>80%)	but	 low	positive	predictive	value	 (15%‐30%).	Assessment	scales	
were	used	to	qualitatively	classify	 the	activity	of	an	 indicator	as	 low,	moderate	or	
high	together	with	a	confidence	level.
Conclusion: We	applied	different	methods	for	 threshold	setting	depending	on	the	
attributes	of	each	parameter	and	 indicator.	For	 indicators	 represented	by	multiple	
parameters,	an	aggregated	assessment	of	the	indicator's	level	of	activity	and	confi-
dence	level	of	the	assessment	was	needed	for	effective	reporting.
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1  | BACKGROUND
Early	severity	assessment	of	pandemic	influenza	is	helpful	for	guid-
ing	 pandemic	 response	 actions.	 However,	 during	 the	 2009	H1N1	
pandemic,	 severity	assessment	was	not	 standardised	across	coun-

















Using	 virological	 and	 surveillance	 data	 from	 different	 sources,	
the	severity	of	each	indicator	can	be	represented	by	more	than	one	
type	of	data,	or	parameter.	The	choice	of	parameters	may	vary	across	
countries	due	 to	different	data	 availability,	 of	which	 some	 require	
substantial	 resource	 to	 collect.	While	 the	 challenge	 of	 data	 com-
parison	remains,	PISA	plays	an	essential	role—to	promote	enhanced	
TA B L E  1  Parameters	considered	for	assessing	severity	of	influenza
Indicator
Singapore parameters 
considered Data source WHO recommended parameters
Transmissibility
How many people in a population 


























How severely sick an individual gets 























How the influenza epidemic or 
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surveillance	and	 increase	 information	sharing	among	public	health	
officials	during	an	influenza	epidemic	or	pandemic.
1.1 | Influenza surveillance in Singapore
Singapore,	a	city‐state	in	South	East	Asia,	is	a	major	global	travel	hub	






we	 expanded	 our	 influenza	 surveillance	 network	 and	 encouraged	
government	 and	 private	 primary	 care	 clinics	 to	 participate	 in	 the	
National	Influenza	Surveillance	Programme.	To	date,	20	government	
primary	care	clinics,	providing	about	20%	of	primary	healthcare	ser-














sion	 in	 the	 community	was	monitored	 using	 the	 average	 daily	 at-
tendance	for	acute	respiratory	infection	(ARI)	and	the	average	daily	
attendance	for	influenza‐like	illness	(ILI)	at	the	government	primary	
care	 clinics.	An	ARI	diagnosis	was	made	when	a	 case	had	at	 least	
one	acute	respiratory	symptom	such	as	cough,	sore	throat	and	co-






Consent	 was	 sought	 for	 the	 collection	 of	 respiratory	 sam-
ples	 from	all	patients	 if	 they	 received	outpatient	 consultation	at	
a	government	or	private	primary	care	clinics	 that	are	enrolled	 in	
the	 National	 Influenza	 Surveillance	 Programme	 and	 presented	
with	 ILI.	 These	 samples	 were	 routinely	 submitted	 to	 the	 NPHL	
and	tested	using	the	FilmArray	Respiratory	Panel	and/or	real‐time	
reverse	 transcription‐polymerase	 chain	 reaction	 (RT‐PCR)	 to	de-
tect	respiratory	viruses.	The	weekly	number	of	samples	was	small	
as	not	all	 identified	patients	participated	 in	the	surveillance,	and	


















parameter's	 variability	 during	 each	 seasonal	 epidemic	 and	 surveil-
lance	 artefacts	 arising	 from	 reporting	 changes.	 These	 two	 factors	
were	considered	in	the	final	selection	of	parameters	used	for	PISA	
reporting.
2.2 | Assessing the transmissibility and 
seriousness of disease indicators’ level of activity































=100 if xw >max (h)
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(ie	alert	thresholds)	to	provide	three	classifications	of	an	indicator's	
level	of	 activity	depending	on	where	 the	average	percentile	 value	




the	confidence	 in	the	assessment	of	an	 indicator's	 level	of	activity	
and	vice	versa.
2.3 | Assessing the impact indicator's 
level of activity




over	 the	 years.	 The	 discrete	 data	 had	 a	 small	 range	 of	 observed	
values,	 and	 hence,	 we	 used	 a	 different	 approach	 to	 set	 the	 alert	





first	 scenario,	 the	moderate	 and	high	 alert	 thresholds	were	 set	 at	
three	and	six,	respectively.	In	the	second	scenario,	they	were	revised	
to	 four	 and	 six,	 respectively.	We	evaluated	key	performance	met-
rics	of	sensitivity,	specificity	and	positive	predictive	value	(PPV)	of	
a	threshold	to	assess	the	threshold's	ability	to	provide	early	warn-








3.1 | Parameters selected for PISA reporting
Time	series	plots	of	the	parameters	in	Table	1	are	shown	in	Figure	1.	
The	 average	 daily	 attendance	 for	 ARI	 at	 the	 government	 primary	
care	clinics	(Figure	1A)	exhibits	a	multimodal	distribution	as	it	is	in-












average	 daily	 number	 of	 influenza‐positive	 ILI	 cases	 at	 the	 gov-















both	ARI	 and	pneumonia	 (Figure	1E‐J).	During	 the	2009	 influenza	
pandemic,	the	weekly	number	of	ARI	ED	attendances	(Figure	1E)	and	
admissions	(Figure	1F)	and,	consequently,	the	weekly	proportion	of	
ARI	ED	attendances	 resulting	 in	 admission	 (Figure	1G)	 indicated	a	
clear	 spike.	One‐off	 adjustment	 in	2016	was	 also	observed	 in	 the	
pneumonia	parameters	 (Figure	1H‐J)	due	 to	change	 in	 the	disease	
classification	 and	 coding	 systems	 of	 some	 hospitals.	 The	 weekly	
proportion	of	ARI	or	pneumonia	ED	attendances	resulting	in	admis-
sion	(Figure	1G,J)	was	selected	as	parameters	for	the	seriousness	of	











3.2 | Performance of the impact parameter 
alert thresholds










F I G U R E  1 







In	 the	second	scenario,	 the	moderate	alert	 threshold	was	 in-
creased	to	a	value	of	4,	and	20	moderate	alerts	were	raised	from	
2011	 to	2017.	Of	 these	 alerts,	 three	 resulted	 in	 sustained	mod-












created	 (Figure	2B)	based	on	the	results	 in	 the	previous	section,	
Performance Matrices for the Impact Parameter Alert Threshold. 




pitals,	 all	 government	 and	 some	private	 primary	 care	 clinics.	 PISA	
indicators	 representing	 the	 transmissibility	of	 influenza	virus,	 seri-
ousness	of	disease	or	the	impact	of	influenza	on	healthcare	resource	
utilisation	highlight	different	aspects	of	influenza	activity.	This	pro-

















8  |     PUNG aNd LEE
platforms	 for	weekly	 reporting.	 In	other	countries,	 the	number	of	
callers	 to	 public	 health	 hotline	 reporting	 ILI7,8	 or	 prescription	 re-

















competing	 requirements	 of	 other	 non‐influenza‐positive	 patients	
depending	 on	 severity.	 Furthermore,	 depending	 on	 a	 hospital's	






Severity	 assessment	 has	 been	 largely	 focused	 on	 developing	
different	methods	to	establish	alert	thresholds	that	signal	the	start	
or	 the	end	of	an	 influenza	season.	Based	on	the	characteristics	of	
a	parameter,12	 a	 variety	of	methods	 such	as	 the	Moving	Epidemic	











F I G U R E  2  Assessment	scale	for	(A)	transmissibility	and	seriousness	of	disease	indicators,	(B)	impact	indicator.	Severity	of	an	indicator	is	
classified	as	L:	low,	M:	moderate,	H:	high.	Confidence	level	of	an	indicator	is	classified	as	1:	low,	2:	medium,	3:	high
TA B L E  2  Weekly	PISA	results
PISA reporting: Transmissibility Seriousness of disease Impact
Year E‐week Risk Confidence Risk Confidence Risk Confidence
2018 1 Moderate Low  Low Medium  High Medium  
2018 2 Moderate Low  Low Medium  High Low  
2018 3 High Low  Moderate High  Moderate Low  
2018 4 High Low  Low High  Low High  
2018 5 High Low  Low High  Low High  
2018 6 High Low  Low High  High Low  
2018 7 Moderate Low  Low Low  Low High  
2018 8 Moderate High  Moderate Low  Moderate Low  
2018 9 Moderate Low  Low Low  Low High  
2018 10 Low Low  Moderate Medium  Moderate Low  









confidence	 level	of	 the	assessment.	With	more	 than	one	parame-
ter	serving	as	proxies	for	an	indicator,	the	method	of	providing	an	
aggregated	assessment	 for	an	 indicator	 remains	undocumented	 in	
PISA.	Furthermore,	 the	confidence	of	an	 indicator's	assessment	 is	
part	 of	 PISA	 reporting,	 but	 its	 interpretation	 is	multifaceted.	 It	 is	
dependent	on,	but	not	 limited	 to,	 reporting	biases,	 timeliness	and	
agreement	between	 the	parameters.	The	 first	 two	 factors	 are	 re-
lated	 to	 the	 reliability	of	 the	 information	provided	at	various	sen-




of	other	 respiratory	viruses.	Thus,	 a	high	agreement	between	 the	
parameters	provides	greater	certainty	to	the	measure	of	an	indica-
tor's	level	of	activity.
The	quantification	of	an	 indicator's	 level	of	activity	 is	achieved	
by	averaging	the	percentile	rank	of	all	the	parameters	representing	







in	 the	clinical	 representation	of	 influenza	cases.	One	possible	way	
of	overcoming	this	challenge	is	to	assign	weights	to	each	parameter	
















The	 effect	 of	 the	 extreme	 parameter	 on	 the	 indicator's	 level	 of	
activity	would	attenuate	when	 the	number	of	parameters	 repre-
senting	an	 indicator	 increases.	Also,	any	sustained	occurrence	of	




We	share	Singapore's	 practices	 in	 the	weekly	 assessment	of	PISA	
indicators.	 For	 indicators	 represented	 by	 multiple	 parameters,	
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